Ascendis Pharma A/S (FRA:A71)
181.00
+3.00 (1.69%)
Last updated: Dec 1, 2025, 8:19 AM CET
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of €11.08 billion as of December 1, 2025. Its market cap has increased by 55.60% in one year.
Market Cap
11.08B
Enterprise Value
11.36B
Revenue
646.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
€181.00
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from 364.37M to 11.08B, an increase of 2,941.27%. That is a compound annual growth rate of 36.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 11.08B | 39.34% |
| Dec 31, 2024 | 7.95B | 23.38% |
| Dec 29, 2023 | 6.45B | 0.95% |
| Dec 30, 2022 | 6.38B | -4.90% |
| Dec 31, 2021 | 6.71B | -8.82% |
| Dec 31, 2020 | 7.36B | 24.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |